Overview
Moderna’s pioneering use of mRNA is a true disruptor in the vaccine space. Investment Manager Julia Angeles explains how Moderna is making drug development a scalable business which resembles a technology company.
UK
Intermediaries
IntermediariesYou are viewing this site as an Intermediaries in UK. You can change this setting at any time. If you confirm now, your location and investor type will be saved for 90 days.
You are viewing this site as an Intermediary in the UK. You can change this at any time. If you confirm these details are correct, we'll save this information.
The details you select will be saved for 90 days.
01. Your location
UKSelect region
Country not listed?
02. Your user type
User type not listed?
Video
Stock story: Moderna
August 2023 / 4 min
